Saturday, December 06, 2025 | 12:33 AM ISTहिंदी में पढें
Page 4 - Glaxosmithkline
Pharma giant GSK buys US cancer drugmaker Tesaro for hefty $5.1 bln
Tesaro boosts GSK's pharma portfolio at high price $75/ share; cash from Horlicks sale to help fund pharma investment
 "Pharma giant GSK buys US cancer drugmaker Tesaro for hefty $5.1 bln")
Updated On : 04 Dec 2018 | 1:11 AM IST
Glaxo seeks mid-Sept bids for $4 billion Indian Horlicks unit: Report
The company is assessing its 72.5 per cent holding in India-listed GlaxoSmithKline Consumer Healthcare Ltd. as part of that process
 "Glaxo seeks mid-Sept bids for $4 billion Indian Horlicks unit: Report")
Updated On : 21 Aug 2018 | 7:28 PM IST
GlaxoSmithKline may split up group, spin off consumer division: Report
Some investors have long called for the group's break-up, arguing that it would crystallise value for component businesses
Updated On : 21 Jul 2018 | 11:40 AM IST
